List of insiders holdings for Cara Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| CSL LTD 10% Owner | 2023-07-25 16:13:19 | 0 7,396,770 | 7,396,770 | Form 3 |
| Vifor (International) Ltd Vifor Pharma Ltd. Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner | 2023-07-25 16:40:49 | 7,396,770 0 | 7,396,770 | Form 13G |
| Moller Charles Ph.D. Director | 2014-02-05 17:09:21 | 0 1,576,404 | 1,576,404 | Form 4 |
| Slagel Dean Director | 2017-07-03 17:53:00 | 0 1,064,338 | 1,064,338 | Form 4 |
| CHALMERS DEREK T President & CEO | 2021-09-09 16:48:51 | 991,405 0 | 991,405 | Form 4 |
| VOGELBAUM MARTIN Director | 2023-06-05 16:29:25 | 199,635 0 | 199,635 | Form 4 |
| Posner Christopher PRESIDENT AND CEO | 2024-03-04 16:19:05 | 180,521 0 | 180,521 | Form 4 |
| Menzaghi Frederique Ph.D. CHIEF SCIENTIFIC OFF,SVP-R&D | 2024-02-05 16:28:07 | 167,247 0 | 167,247 | Form 4 |
| Boudreau Helen M Director | 2023-08-04 17:20:52 | 155,747 0 | 155,747 | Form 4 |
| Medve Robert Chief Medical Officer | 2014-06-19 14:24:01 | 120,000 0 | 120,000 | Form 4 |
| BAINS HARRISON M JR Director | 2023-06-05 16:31:05 | 102,399 0 | 102,399 | Form 4 |
| Shiff Susan Ph.D. Director | 2023-06-05 16:34:32 | 96,399 0 | 96,399 | Form 4 |
| Ives Jeffrey L. Director | 2023-06-05 16:33:22 | 92,799 0 | 92,799 | Form 4 |
| Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | 2024-04-09 16:21:00 | 88,247 0 | 88,247 | Form 4 |
| von Moltke Lisa Director | 2023-06-05 16:36:25 | 77,323 0 | 77,323 | Form 4 |
| Goncalves Joana CHIEF MEDICAL OFFICER | 2024-04-09 16:22:02 | 53,365 0 | 53,365 | Form 4 |
| Schoell Josef Chief Financial Officer | 2017-07-28 16:53:40 | 50,000 0 | 50,000 | Form 4 |
| ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC CHAMPSI FARAH HURWITZ EDWARD PENHOET EDWARD 10% Owner | 2014-02-05 16:54:37 | 0 43,212 | 43,212 | Form 4 |
| Reilly Thomas Charles Chief Financial Officer | 2022-03-04 17:54:51 | 37,811 0 | 37,811 | Form 4 |
| Lewis Michael E Chief Scientific Advisor | 2017-03-10 17:21:57 | 20,000 0 | 20,000 | Form 4 |
| Mohindru Mani CFO & Chief Strategy Officer | 2019-12-04 19:50:59 | 17,441 0 | 17,441 | Form 4 |
| Makara Richard VP, Head of Accting;Controller | 2022-06-16 17:14:11 | 13,583 0 | 13,583 | Form 4 |
| Maynard Ryan D CHIEF FINANCIAL OFFICER | 2024-02-12 17:15:08 | 8012 0 | 8012 | Form 4 |
| Stauffer Joseph William Chief Medical Officer | 2018-10-19 16:34:47 | 2000 0 | 2000 | Form 4 |
| RHO Ventures VI LP RMV VI L.L.C. Rho Capital Partners LLC LESCHLY MARK KAIROUZ HABIB RUCH JOSHUA 10% Owner | 2022-02-14 11:35:51 | 782 0 | 782 | Form 13G |